Clinical Assay for Exposure Therapy

The Clinical Assay Working Group has two main goals. The first is to develop a clinical assay to (1) guide clinicians in measuring session success and (2) inform research on the development of augmentation strategies. The second goal is to establish the clinical assay as a translational tool that bridges basic non-human animal and human research with clinical trial methodology, ultimately providing a structured step between basic research and clinical trials, helping reduce costs, improve trial design, and increase the likelihood of successful translation to practice.

Advantages

There are several advantages to this line of inquiry:

01.

Enhanced Treatment Efficacy

Clinical assays can help identify what works best for individual patients in real time. This supports the development of targeted augmentation strategies that enhance overall treatment outcomes.

02.

Improved Measurement

It provides a standardized method for evaluating therapeutic sessions. This ensures consistent, objective measurement that informs both clinical decisions and research progress.

03.

Cost Reduction

By serving as a structured bridge between basic research and clinical trials, the clinical assay streamlines the translation process. This reduces trial inefficiencies and associated costs while improving study design.

04.

Effective Guidance

The assay offers clinicians actionable insights into treatment progress and success. These data-driven indicators guide decision-making and optimize therapy approaches for better patient care.